Revenue: The sum of all revenue fields included for a company's operating activities.
Harmony Biosciences Holdings, Inc. (HRMY) had Revenue of $215.39M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$215.39M |
$32.49M |
|
$44.51M |
|
$170.88M |
|
$178.10M |
|
$37.29M |
|
$2.40M |
|
$39.69M |
|
$39.69M |
|
$32.49M |
|
$32.49M |
|
$32.49M |
|
$32.49M |
|
$37.29M |
|
$43.19M |
|
57.82M |
|
58.78M |
|
$0.56 |
|
$0.55 |
|
| Balance Sheet Financials | |
$778.82M |
|
-- |
|
$493.01M |
|
$1.27B |
|
$217.34M |
|
$138.81M |
|
$144.13M |
|
$361.48M |
|
$910.35M |
|
$826.89M |
|
$910.35M |
|
57.87M |
|
| Cash Flow Statement Financials | |
$27.76M |
|
$-183.65M |
|
$-7.22M |
|
$752.77M |
|
$589.67M |
|
$-163.10M |
|
$10.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.58 |
|
-- |
|
-- |
|
0.13 |
|
0.17 |
|
79.33% |
|
17.31% |
|
17.31% |
|
-- |
|
18.43% |
|
15.08% |
|
$27.76M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
8.43 |
|
1.99 |
|
45.22 |
|
3.57% |
|
3.93% |
|
2.55% |
|
3.10% |
|
$15.73 |
|
$0.47 |
|
$0.47 |
|